Endoresection With Adjuvant Ruthenium Brachytherapy for Selected Uveal Melanoma Patients - The Tuebingen Experience

Acta Ophthalmologica - United States
doi 10.1111/aos.13306
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Ruthenium-106 Brachytherapy in Treatment of Uveal Melanoma: 50 Years of Use!

BIO Web of Conferences
2019English

Intrascleral Recurrence of Uveal Melanoma After Transretinal "Endoresection"

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2001English

Post-Brachytherapy Tumor Endoresection for Treatment of Toxic Maculopathy in Choroidal Melanoma

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2013English

Adjuvant Ipilimumab in High-Risk Uveal Melanoma

Cancers
Cancer ResearchOncology
2019English

Gamma Knife Radiosurgery for Uveal Melanoma Ineligible for Brachytherapy by the Collaborative Ocular Melanoma Study Criteria

Open Access Surgery
Sports MedicineAnesthesiologyTransplantationOrthopedicsSurgeryPain Medicine
2008English

Post-Brachytherapy Initial Tumour Regression Rate Correlates With Metastatic Spread in Posterior Uveal Melanoma

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2004English

Proton Therapy for Uveal Melanoma in 43 Juvenile Patients

Ophthalmology
Ophthalmology
2014English

A Novel Four‑snoRNA Signature for Predicting the Survival of Patients With Uveal Melanoma

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

Imaging Modalities for Uveal Melanoma

European Ophthalmic Review
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy